Pelthos Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MURCHINSON LTD. | 05/15/2026 | 296.31 K | $6.23 M | 2.36% | 8.95% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 256.60 K | $5.39 M | 0.33% | 7.75% |
| 05/15/2026 | 93.09 K | $1.96 M | 100.00% | 2.81% | |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 81.86 K | $1.72 M | 1.46% | 2.47% |
| J. GOLDMAN & CO LP | 05/15/2026 | 50.42 K | $1.06 M | -35.37% | 1.52% |
| CANTOR FITZGERALD, L. P. | 05/15/2026 | 41.42 K | $870.30 K | 18.39% | 1.25% |
| DIADEMA PARTNERS LP | 05/15/2026 | 24.77 K | $520.48 K | -0.91% | 0.75% |
| KNOTT DAVID M JR | 05/14/2026 | 21.07 K | $442.74 K | 9.29% | 0.64% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 15.29 K | $321.24 K | 12.22% | 0.46% |
| PALE FIRE CAPITAL SE | 05/14/2026 | 12.92 K | $271.43 K | 59.49% | 0.39% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 9.82 K | $206.26 K | 100.00% | 0.30% |
| PERSISTENT ASSET PARTNERS LTD | 05/12/2026 | 6.01 K | $126.21 K | 0.00% | 0.18% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/08/2026 | 1.91 K | $40.13 K | 0.00% | 0.06% |
| UBS GROUP AG | 05/05/2026 | 764 | $16.05 K | 76.04% | 0.02% |
| FARTHER FINANCE ADVISORS, LLC | 04/07/2026 | 40 | $852 | 100.00% | 0.00% |
| ASPECT PARTNERS, LLC | 04/02/2026 | 16 | $336 | 100.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 1 | $21 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Pelthos Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 19 institutional investors and hedge funds held shares of Pelthos Therapeutics Inc.. The most heavily invested institutionals were:
Murchinson Ltd.: 296,314
Ikarian Capital, LLC: 256,598
BOOTHBAY FUND MANAGEMENT, LLC: 81,858
J. Goldman & Co LP: 50,415
CANTOR FITZGERALD, L. P.: 41,423
DIADEMA PARTNERS LP: 24,773
27.55% of Pelthos Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 894.24 K shares in the last 24 months. This purchase volume represents approximately $21.20 M in transactions.